PRIMARY GRAFT FAILURE in the early postoperative period after heart transplantation
is a severe complication, potentially leading to multiorgan failure, presenting with
a poor outcome. It seems to be the result of poor donor conditions, acute cellular
and humoral rejection, and prolonged ischemia time.
1
Therapeutic options are limited to pharmacologic support with catecholamines and
phosphodiesterase inhibitors. Mechanical support with intra-aortic counterpulsation
or extracorporeal membrane oxygenation (ECMO) may be necessary in severe cases of
primary graft failure.
1
,
2
Key words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Cardiothoracic and Vascular AnesthesiaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Primary graft failure in heart transplantation: A multivariate analysis.Transplant Proc. 1998; 30: 1932
- Primary graft failure after heart transplantation.Int J Artif Organs. 1996; 19: 307-310
- Levosimendan in cardiac surgery: current best available evidence.Ann Thorac Surg. 2006; 81: 1536-1546
- The effects of levosimendan in cardiac surgery patients with poor left ventricular function.Anesth Analg. 2007; 104: 766-773
- Effects of levosimendan on right ventricular function in patients with advanced heart failure.Am J Cardiol. 2006; 98: 1489-1492
- Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.Crit Care Med. 2006; 34: 2814-2819
- Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.Int J Clin Pract. 2008; 62: 228-233
- Levosimendan treatment after primary organ failure in heart transplantation: A direct way to recovery?.Transplantation. 2006; 82: 1101-1103
- Acute allograft failure in thoracic organ transplantation.J Card Surg. 2000; 15: 122-128
- Expanding the heart donor base.Curr Opin Organ Transplant. 2007; 5: 134-138
- Outcomes of pediatric patients bridged to heart transplantation from extracorporeal membrane oxygenation support.ASAIO J. 2007; 53: 97-102
- Early institution of mechanical support improves outcomes in primary cardiac allograft failure.J Heart Lung Transplant. 2005; 24: 2037-2042
- Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: Analysis of the Extracorporeal Life Support Organization (ELSO) registry.J Heart Lung Transplant. 2007; 26: 472-477
- Outcome for pediatric cardiac transplantation with and without bridge methods.ASAIO J. 2007; 53: 241-245
- Late vascular complications after extracorporeal membrane oxygenation support.Ann Thorac Surg. 2006; 81: 892-895
- Levosimendan, a new inotropic and vasodilator agent.Anesthesiology. 2006; 104: 556-569
Article info
Publication history
Published online: March 17, 2008
Footnotes
D. Hauer and A. Beiras-Fernandez contributed equally to this work.
Identification
Copyright
© 2009 Elsevier Inc. Published by Elsevier Inc. All rights reserved.